90 results
10-K
2023 FY
EX-10.13
ATOS
Atossa Therapeutics Inc
Annual report
1 Apr 24
4:05pm
10-K
2023 FY
EX-10.12
ATOS
Atossa Therapeutics Inc
Annual report
1 Apr 24
4:05pm
10-K
2022 FY
EX-10.3
ATOS
Atossa Therapeutics Inc
Annual report
22 Mar 23
4:10pm
8-K
EX-10.2
ATOS
Atossa Therapeutics Inc
22 Dec 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
ATOS
Atossa Therapeutics Inc
22 Dec 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
2mx 5eqmtqc3vp533q
5 Aug 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
63rxvi2a2uibi
27 May 16
Atossa Genetics Announces $10 Million At-the-Market
12:00am
8-K
EX-10.1
3sl8tg 5v
20 May 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
j7jznh8 d4261j
8 Feb 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
fv4b6d8u787qwvbz
16 Dec 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
iae5no
4 Sep 15
Announces Appointment of Scott Youmans as Chief Operating Officer
12:00am
8-K
EX-10.2
us7363
10 Jun 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
5a63ick
10 Jun 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
fz6 aj8ec
28 May 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
9vwwozh3g2s9
18 May 15
Entry into a Material Definitive Agreement
12:00am